Radiation Therapy for Brain Tumours: Understanding SRS vs SRT

What stereotactic treatment means

Stereotactic treatment combines detailed imaging, rigidly reproducible positioning, small margins and steep dose fall-off. It can treat selected brain metastases, benign tumours and other intracranial conditions. The prescription and target definition differ by diagnosis.

Precision reduces unnecessary exposure but does not eliminate normal-brain dose. Planning evaluates target coverage and dose-volume limits associated with swelling or radionecrosis risk.

How SRS and SRT differ

SRS commonly means one high-dose fraction, while fractionated SRT may use three to five or more sessions. Dividing dose allows normal tissues some recovery between fractions and may be preferred for larger targets or lesions near sensitive structures.

Terminology varies among centres. Ask for the actual number of fractions and dose rather than relying only on the label radiosurgery.

Which clinical factors guide selection

The team considers pathology, target volume, symptoms, swelling, resection status, number of lesions and extracranial disease. A small lesion beside the optic pathway may need a different schedule from a similar-sized lesion in a less constrained location.

For brain metastases, systemic treatment options, prognosis and total intracranial disease matter. Whole-brain radiation, surgery, observation or medicines may be relevant alternatives or partners.

Mask, MRI and treatment planning

A custom thermoplastic mask supports reproducibility. Thin-slice planning CT is usually combined with contrast-enhanced MRI. The radiation oncologist and planning team outline the target and critical structures with millimetre-level attention.

At treatment, high-quality imaging verifies position. Some systems use a frame rather than a mask for selected single-fraction procedures. Each workflow has specific accuracy and patient-experience considerations.

Side effects and radionecrosis

Short-term effects can include fatigue, headache, nausea, temporary swelling or focal symptoms depending on location. Steroids may be used for oedema but have their own side effects. Seizure medicines are not automatically needed for every patient.

Radiation necrosis is delayed injury that can resemble tumour progression on imaging. Risk depends on volume, dose, prior radiation and combined treatments. Further imaging, observation, medicines, surgery or other interventions may be required.

Follow-up after stereotactic radiation

MRI follow-up assesses treated lesions and looks for new disease. Early changes can be difficult to interpret, so a single scan may not provide a final answer. Symptoms and serial imaging guide decisions.

Report new weakness, seizure, severe headache, repeated vomiting, confusion, speech change or vision loss urgently. Routine follow-up is not an emergency pathway.

Turn general information into a useful medical discussion

Start by writing down the parts of this guide that appear relevant and the parts that do not match what you have been told. Do not use an online article to change medicines, skip an investigation or delay treatment on your own. Instead, ask the treating team to connect the general principle to your diagnosis, stage and treatment intent. If a term in the report is unclear, request the exact wording and an explanation in language you can repeat back.

Bring the pathology report, the actual CT, MRI or PET images as well as their written reports, operation notes, previous treatment summaries, current medicines and recent blood tests. Previous radiation needs special attention: a safe re-irradiation opinion may require the original digital plan, dose distribution and structure set, not only a discharge card. Sending records before the visit can leave more appointment time for decisions and questions.

It can help to create a one-page timeline with the biopsy date, major scan dates, surgery, medicine cycles and the recommendation currently being considered. Add your most important priorities, such as preserving an organ, reducing travel, maintaining work, fertility, urinary or bowel function, or understanding the chance of needing additional treatment. These priorities do not replace cancer-control considerations, but they help the doctor compare medically reasonable options in a way that fits your life.

Finally, distinguish urgent symptoms from decision questions. New weakness, severe bleeding, breathing difficulty, uncontrolled pain, confusion, fever or inability to drink may need prompt hospital assessment rather than a routine appointment or WhatsApp exchange. For a non-urgent decision, leave the consultation with a written next step, the expected time frame and a contact point for questions that arise after you review the discussion with your family.

Look beyond reassuring words and technology labels

Cancer information often uses words such as precision, advanced, targeted or minimally invasive. These terms can describe useful capabilities, but they do not prove that a treatment is appropriate or superior for one person. Ask what clinical problem a technique solves, what evidence supports it for your diagnosis and stage, and whether a simpler or different option could achieve the same goal. A machine brand, session count or dramatic dose image should never replace an explanation of treatment intent and expected benefit.

Useful comparisons include the complete pathway: preparation, other treatments, likely side effects, recovery, follow-up and the chance that additional treatment will be needed. Ask the clinician to separate common effects from rare serious risks and to state where evidence is strong, uncertain or based mainly on patient selection. If percentages are quoted, ask which group they came from and whether that group resembles your situation.

High-quality care also includes processes patients may not see: pathology and imaging review, contouring, peer discussion, physics quality assurance, image guidance, symptom support and a plan for anatomical change. These processes are less marketable than a machine name but often determine whether technology is used well. The best consultation should make the reasoning clearer, not simply make the treatment sound impressive.